SAN DIEGO, July 01, 2025--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), announced today that, on July 7, 2025, the Company will implement a 1-for-3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback